These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 21976009)
1. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009 [TBL] [Abstract][Full Text] [Related]
2. Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. Hui MK; Lai KK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S Med Oncol; 2012 Dec; 29(5):3009-16. PubMed ID: 22528514 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma. Takata A; Takiguchi S; Okada K; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y Anticancer Res; 2014 May; 34(5):2427-32. PubMed ID: 24778055 [TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
5. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma. Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046 [TBL] [Abstract][Full Text] [Related]
6. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. Hui MK; Lai KK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S Med Oncol; 2012 Sep; 29(3):1699-706. PubMed ID: 22086736 [TBL] [Abstract][Full Text] [Related]
8. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma]. Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. He Z; Yi J; Jin L; Pan B; Chen L; Song H Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma. Zhang H; Chen W; Duan CJ; Zhang CF World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267 [TBL] [Abstract][Full Text] [Related]
12. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844 [TBL] [Abstract][Full Text] [Related]
13. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma. Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma. Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755 [TBL] [Abstract][Full Text] [Related]
16. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related]
17. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881 [TBL] [Abstract][Full Text] [Related]
19. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma. Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860 [TBL] [Abstract][Full Text] [Related]
20. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients. Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]